Clinical Trials Logo

Clinical Trial Summary

This study is a phase 3, randomized, multi-center study to evaluate the efficacy and safety of the NT-501 implants in participants with macular telangiectasia type 2.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03319849
Study type Interventional
Source Neurotech Pharmaceuticals
Contact
Status Completed
Phase Phase 3
Start date February 6, 2018
Completion date September 23, 2022

See also
  Status Clinical Trial Phase
Completed NCT03316300 - A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A Phase 3
Completed NCT04729972 - Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2 Phase 2
Active, not recruiting NCT04907084 - Serine and Fenofibrate Study in Patients With MacTel Type 2 Phase 2
Completed NCT01949324 - A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel Phase 2
Not yet recruiting NCT06397131 - A Study to Determine the Safety and Efficacy of NT-501 With MHFM Phase 3